tiprankstipranks
Trending News
More News >
Advertisement

GB:MRN3 ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Neutral
10Bullish
4Neutral
8Bearish
Oscillators
Neutral
3Bullish
4Neutral
3Bearish
Moving Averages
Buy
7Bullish
0Neutral
5Bearish
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Moving Averages Convergence Divergence (MACD) indicator is -0.33, suggesting Leverage Shares 3x Long Moderna (MRNA) ETP Securities is a Sell.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 20-Day exponential moving average is 6.13, making it a Buy.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 50-Day exponential moving average is 7.63, making it a Buy.

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3) Pivot Points

Oct 03, 2025, 08:10 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.44
4.85
5.05
5.46
5.66
6.07
6.27
Fibonacci
4.85
5.08
5.22
5.46
5.69
5.83
6.07

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3) Moving Averages

Oct 03, 2025, 08:10 PM
Period
Simple
Exponential
MA5
5.79Buy
6.23Buy
MA10
6.08Buy
6.04Buy
MA20
5.83Buy
6.13Buy
MA50
7.83Sell
7.63Buy
MA100
9.36Sell
17.01Sell
MA200
26.91Sell
59.46Sell
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 10-Day exponential moving average is 6.04, making it a Buy.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 100-Day exponential moving average is 17.01, making it a Sell.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 50-day simple moving average is 7.83, creating a Sell signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 100-day simple moving average is 9.36, creating a Sell signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 200-day simple moving average is 26.91, creating a Sell signal.

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3) Technical Analysis

Oct 03, 2025, 08:10 PM
Name
Value
Action
RSI (14)
57.34
Neutral
STOCH (9,6)
45.06
Neutral
STOCHRSI (14)
49.38
Neutral
MACD (12,26)
-0.33
Sell
ADX (14)
19.06
Buy
Williams %R
-3.93
Sell
CCI (14)
208.08
Sell
ATR (14)
0.92
-
Ultimate Oscillator
53.56
Neutral
ROC
26.94
Buy
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Relative Strength Index (RSI) is 57.34, creating a Neutral signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Trend Strength Indicator (ADX) is 19.06, creating a Buy signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Commodity Channel Index (CCI) is 208.08, creating a Sell signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Price Rate of Change (ROC) is 26.94, creating a Buy signal.

FAQ

Is MRN3 a Buy, Hold, or Sell?
Based on MRN3’s technical indicators, MRN3 is a Hold.
    What is MRN3’s RSI (14)?
    MRN3’s RSI (14) is 57.34, which suggests MRN3 is a Neutral.
      What is MRN3’s MACD?
      MRN3’s MACD is -0.33, which suggests MRN3 is a Sell.
        What is MRN3’s 5-day moving average?
        MRN3’s 5-day moving average is 5.79, which suggests MRN3 is a Buy.
          What is MRN3’s 20-day moving average?
          MRN3 20-day moving average is 5.83, which suggests MRN3 is a Buy.
            What is MRN3’s 50-day moving average?
            MRN3’s 50-day moving average is 7.83, which suggests MRN3 is a Sell.
              What is MRN3’s 200-day moving average?
              MRN3’s 200-day moving average is 26.91, which suggests MRN3 is a Sell.
                What is MRN3’s Williams % R (14)?
                MRN3’s Williams % R (14) is -3.93, which suggests MRN3 is a Sell.
                  What is MRN3’s CCI (14)?
                  MRN3’s CCI (14) is 208.08, which suggests MRN3 is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement